Isotopia, Eckert & Ziegler partner

By staff writers

February 18, 2020 -- Isotopia Molecular Imaging has partnered with isotope technology firm Eckert & Ziegler for the development of its PSMA-11 kit for prostate cancer imaging.

The companies will finalize the development of Isotopia's gallium-68-HBED-CC-PSMA (gallium-68-PSMA-11) kit, which is used for the imaging and staging of prostate cancer.

The collaboration includes making the kit feasible on Eckert & Ziegler's KitLab, having its GalliaPharm in the drug master file of the kit, and completing the necessary steps to obtain marketing authorization in the European Union.

PSMA-11 is a small molecule that binds to prostate-specific membrane antigen (PSMA). When radiolabeled with gallium-68, it is a convenient, clinically efficient approach to imaging prostate cancer with PET, according to the company.

Copyright © 2020

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking